AI In Pharma Market Report 2023

AI In Pharma Global Market Report 2023 – By Technology (Context Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $4000.00 | Pages : 200 | Published : January 2023 | Delivery Time: 2-3 business days | Format :

Need assistance or more information before the purchase?

Enquire Before Buying
AI In Pharma Market

Proud Members Of

AI in pharma refers to the use of automated algorithms to jobs that normally need human intelligence. Large datasets including disease patterns can be successfully identified by AI solutions in pharma, and they can also assist in understanding which medication formulations would be most effective for treating certain ailments.

The artificial intelligence (AI) in the pharma market covered in the report is segmented by technology into context-aware processing, natural language processing, querying method, and deep learning; by drug type into the small molecule, large molecules; by application into diagnosis, clinical trial research, drug discovery, research and development, epidemic prediction.

The global ai in pharma market is segmented -

1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning

2) By Drug Type: Small Molecule, Large Molecules

3) By Application: Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction

The global AI in pharma market size will grow from $1.24 billion in 2022 to $1.64 billion in 2023 at a compound annual growth rate (CAGR) of 32.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the AI in pharma is expected to grow to $4.61 billion in 2027 at a CAGR of 29.4%.

The growing adoption of artificial intelligence (AI) for clinical trials research is driving its demand for AI in the pharmaceutical market. To bring a new drug to the market takes on an average 10–15 years approximately and half of this time is consumed during the clinical trial phases of the drug development cycle. Hence, using AI models and analytics tools can accelerate the clinical trial phases, perception of diseases, identify suitable cases and key investigators to inform site selection, and support novel clinical study designs. For instance, in January 2020, Pfizer, an American pharmaceutical company, tied up with a biotech startupInsilico Medicine to identify drug targets. With AI tools Pfizer can speed up drug discovery and reduce drug development costs in the drug development processes. Thus, increasing the adoption of AI for clinical trials research is driving AI in the pharma market growth.

Major players in the AI in pharma market are Novartis, IBM Watson, Microsoft Corporation, Merck, GNS Healthcare., Google, AstraZeneca, Atomwise, Inc., Exscientia, and Cyclica.

A lack of skilled professionals may hamper the growth of artificial intelligence in the pharma market. In 2022, according to the report published by UNLEASH, a UK-based digital media platform, IBM, and Morning Consult conducted surveys of more than 1,000 tech job seekers, more than 600 tech workers, and more than 300 tech recruiters in the UK, Spain, and Germany to determine the AI skills gap in Europe and found around 28% of recruiters report having difficulty locating candidates with deep learning, machine learning, and data engineering and analytics experience. The shortage of AI skills is seen as a major barrier to the pace of technology’s adoption. In fact, 56% of senior AI professionals thought that a lack of additional, qualified AI workers was the single most important hurdle to be overcome in terms of obtaining the necessary level of AI implementation beyond business operations. Therefore, the lack of skilled professionals may hamper the growth of AI in the pharma market.

Companies operating in the AI for the pharma market are introducing new AI tools that will be beneficial for the pharma companies and this is a key trend in AI in the pharma market. AI helps in quality control, predictive maintenance, waste reduction, design optimization, and process automation. For instance, in August 2022, Sanford Health, a US-based non-profit, integrated healthcare delivery system,and Sharp HealthCare, a US-based non-profit organization in healthcarepartnered with Dandelion Health, a US-based healthcare artificial intelligence (AI) company, introduced a comprehensive data platform that gives health institutions access to high-quality, representative patient data for clinical AI development. The Dandelion Platform is made to give health AI developers secure, ethical access to patient datasets which includes include images, waveforms, and structured health records, so they may make tools and products that will help patients and clinicians.

In October 2021, Nurosene Health Inc., a Canada-based company focused on delivering innovative AI-based technology solutions that support mental performance and wellness acquired Netramark Incorporated for an undisclosed amount. Through this acquisition, Nurosene Health Inc aims to strengthen its capabilities in AI-based neuroscience product offerings. Netramark Incorporated is a Canada-based pharma tech company that utilizes AI, novel mathematical methods, and quantum computing to optimize new drug development, clinical trials, treatment, and diagnosis.

North America was the largest region in the AI in pharma market in 2022. The regions covered in the AI in pharma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the AI in pharma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The AI in pharma market includes revenues earned by entities by implementing quality control, addressing supply chain problems in the production line, and minimising material waste. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The artificial intelligence (AI) in pharma market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in pharma market statistics, including artificial intelligence (AI) in pharma industry global market size, regional shares, competitors with artificial intelligence (AI) in pharma market share, detailed artificial intelligence (AI) in pharma market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in pharma industry. This artificial intelligence (AI) in pharma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. AI In Pharma Market Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6.  Introduction

    6.1. Segmentation By Geography

    6.2. Segmentation By Technology

    6.3. Segmentation By Drug Type

    6.4. Segmentation By Application

    7.   AI In Pharma Market Characteristics

    7.1. Market Definition

    7.2. Segmentation By Technology

    7.2.1. Context-Aware Processing

    7.2.2. Natural Language Processing

    7.2.3. Querying Method

    7.2.4. Deep Learning

    7.3. Market Segmentation By Drug Type

    7.3.1. Small Molecules

    7.3.2. Large Molecules

    7.4. Segmentation By Application

    7.4.1. Clinical Trial Research

    7.4.2. Drug Discovery

    7.4.3. Research And Development

    7.4.4. Others

    8.  AI In Pharma Market Trends And Strategies

    8.1. Use Of AI For Clinical Trials

    8.2. AI For Rare Diseases Treatment

    8.3. AI For Drug Adherence

    8.4. Investments in AI Driven Biotech Firms

    8.5. Rise In Merger And Acquisition Activity

    8.6. Introduction of New Artificial Intelligence (AI) Tools

    8.7. Emerging Role of CROs in AI Ecosystems

    8.8. Introduction of AI Innovation Labs

    9.  Impact Of COVID-19 On The AI In Pharma Market

    9.1. Introduction

    9.2. Use Of AI For Vaccine Development

    9.3. Clinical Trials

    9.4. Future Outlook

    10. Global AI In Pharma Market Size And Growth

    10.1. Market Size

    10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

    10.2.1. Drivers Of The Market 2015 – 2020

    10.2.2. Restraints On The Market 2015 – 2020

    10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    10.3.1. Drivers Of The Market 2020 – 2025

    10.3.2. Restraints On The Market 2020 – 2025

    11. Global AI In Pharma Market Segmentation

    11.1. Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.2. Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.3. Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    12. AI In Pharma Market, Regional And Country Analysis

    12.1. Global AI In Pharma Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    12.2. Global AI In Pharma Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13. Asia-Pacific AI In Pharma Market

    13.1. Asia-Pacific AI In Pharma Market Overview

    13.1.1. Region Information

    13.1.2. Market Information

    13.1.3. COVID-19 Impact

    13.1.4. Background Information

    13.1.5. Government Initiatives

    13.1.6. Regulations

    13.1.7. Regulatory Bodies

    13.1.8. Major Associations

    13.1.9. Taxes levied

    13.1.10. Corporate Tax Structure

    13.1.11. Investments

    13.1.12. Major Companies

    13.2. Asia-Pacific AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.3. Asia-Pacific AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.4. Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.5. Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.6. Asia-Pacific AI In Pharma Market: Country Analysis

    13.7. China AI In Pharma Market

    13.8. China AI In Pharma Market Overview

    13.8.1. Country Information

    13.8.2. Market Information

    13.8.3. COVID-19 Impact

    13.8.4. Background Information

    13.8.5. Government Initiatives

    13.8.6. Regulations

    13.8.7. Regulatory Bodies

    13.8.8. Major Associations

    13.8.9. Taxes Levied

    13.8.10. Corporate Tax Structure

    13.8.11. Investments

    13.8.12. Major Companies

    13.9. China AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.10. China AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.11. China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.12. China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.13. India AI In Pharma Market

    13.14. India AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.15. India AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.16. India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.17. India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.18. Japan AI In Pharma Market

    13.19. Japan AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.20. Japan AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.21. Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.22. Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.23. Australia AI In Pharma Market

    13.24. Australia AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.25. Australia AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.26. Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.27. Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.28. Indonesia AI In Pharma Market

    13.29. Indonesia AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.30. Indonesia AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.31. Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.32. Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.33. South Korea AI In Pharma Market

    13.34. South Korea AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.35. South Korea AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    13.36. South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.37. South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14. Western Europe AI In Pharma Market

    14.1. Western Europe AI In Pharma Market Overview

    14.1.1. Region Information

    14.1.2. Market Information

    14.1.3. COVID-19 Impact

    14.1.4. Background Information

    14.1.5. Government Initiatives

    14.1.6. Regulations

    14.1.7. Regulatory Bodies

    14.1.8. Major Associations

    14.1.9. Taxes Levied

    14.1.10. Corporate Tax Structure

    14.1.11. Investments

    14.1.12. Major Companies

    14.2. Western Europe AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.3. Western Europe AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.4. Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.5. Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.6. Western Europe AI In Pharma Market: Country Analysis

    14.7. UK AI In Pharma Market

    14.8. UK AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.9. UK AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.10. UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.11. UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.12. Germany AI In Pharma Market

    14.13. Germany AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.14. Germany AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.15. Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.16. Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.17. France AI In Pharma Market

    14.18. France AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.19. France AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    14.20. France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.21. France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15. Eastern Europe AI In Pharma Market

    15.1. Eastern Europe AI In Pharma Market Overview

    15.1.1. Region Information

    15.1.2. Market Information

    15.1.3. COVID-19 Impact

    15.1.4. Background Information

    15.1.5. Government Initiatives

    15.1.6. Regulations

    15.1.7. Regulatory Bodies

    15.1.8. Major Associations

    15.1.9. Taxes Levied

    15.1.10. Corporate Tax Structure

    15.1.11. Investments

    15.1.12. Major Companies

    15.2. Eastern Europe AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    15.3. Eastern Europe AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    15.4. Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.5. Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.6. Eastern Europe AI In Pharma Market: Country Analysis

    15.7. Russia AI In Pharma Market

    15.8. Russia AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    15.9. Russia AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    15.10. Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.11. Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16. North America AI In Pharma Market

    16.1. North America AI In Pharma Market Overview

    16.1.1. Region Information

    16.1.2. Market Information

    16.1.3. COVID-19 Impact

    16.1.4. Background Information

    16.1.5. Government Initiatives

    16.1.6. Regulations

    16.1.7. Regulatory Bodies

    16.1.8. Major Associations

    16.1.9. Taxes Levied

    16.1.10. Corporate Tax Structure

    16.1.11. Investments

    16.1.12. Major Companies

    16.2. North America AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.3. North America AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    16.4. North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.5. North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.6. North America AI In Pharma Market: Country Analysis

    16.7. USA AI In Pharma Market

    16.8. USA AI In Pharma Market Overview

    16.8.1. Country Information

    16.8.2. Market Information

    16.8.3. COVID-19 Impact

    16.8.4. Background Information

    16.8.5. Government Initiatives

    16.8.6. Regulations

    16.8.7. Regulatory Bodies

    16.8.8. Major Associations

    16.8.9. Taxes Levied

    16.8.10. Corporate Tax Structure

    16.8.11. Investments

    16.8.12. Major Companies

    16.9. USA AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.10. USA AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    16.11. USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.12. USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17. South America AI In Pharma Market

    17.1. South America AI In Pharma Market Overview

    17.1.1. Region Information

    17.1.2. Market Information

    17.1.3. COVID-19 Impact

    17.1.4. Background Information

    17.1.5. Government Initiatives

    17.1.6. Regulations

    17.1.7. Regulatory Bodies

    17.1.8. Major Associations

    17.1.9. Taxes Levied

    17.1.10. Corporate Tax Structure

    17.1.11. Investments

    17.1.12. Major Companies

    17.2. South America AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    17.3. South America AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    17.4. South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.5. South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.6. South America AI In Pharma Market: Country Analysis

    17.7. Brazil AI In Pharma Market

    17.8. Brazil AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    17.9. Brazil AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    17.10. Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.11. Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    18. Middle East AI In Pharma Market

    18.1. Middle East AI In Pharma Market Overview

    18.1.1. Region Information

    18.1.2. Market Information

    18.1.3. COVID-19 Impact

    18.1.4. Background Information

    18.1.5. Government Initiatives

    18.1.6. Regulations

    18.1.7. Regulatory Bodies

    18.1.8. Major Associations

    18.1.9. Taxes Levied

    18.1.10. Corporate Tax Structure

    18.1.11. Investments

    18.1.12. Major Companies

    18.2. Middle East AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    18.3. Middle East AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    18.4. Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    18.5. Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19. Africa AI In Pharma Market

    19.1. Africa AI In Pharma Market Overview

    19.1.1. Region Information

    19.1.2. Market Information

    19.1.3. COVID-19 Impact

    19.1.4. Background Information

    19.1.5. Government Initiatives

    19.1.6. Regulations

    19.1.7. Regulatory Bodies

    19.1.8. Major Associations

    19.1.9. Taxes levied

    19.1.10. Corporate Tax Structure

    19.1.11. Investments

    19.1.12. Major Companies

    19.2. Africa AI In Pharma Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.3. Africa AI In Pharma Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

    19.4. Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.5. Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    20. Global AI In Pharma Market Competitive Landscape

    20.1. Company Profiles

    20.2. IBM Watson Health

    20.2.1. Company Overview

    20.2.2. Products And Services.

    20.2.3. Business Strategy

    20.2.4. Financial Overview

    20.3. Alphabet Inc.

    20.3.1. Company Overview

    20.3.2. Products And Services

    20.3.3. Business Strategy

    20.3.4. Financial Overview

    20.4. Concreto HealthAI

    20.4.1. Company Overview

    20.4.2. Products And Services

    20.4.3. Business Strategy

    20.4.4. Financial Overview

    20.5. Nvidia Corporation

    20.5.1. Company Overview

    20.5.2. Products And Services

    20.5.3. Business Strategy

    20.5.4. Financial Overview

    20.6. PathAI

    20.6.1. Company Overview

    20.6.2. Products And Services

    20.6.3. Business Strategy

    20.6.4. Financial Overview

    21. Key Mergers And Acquisitions In The AI In Pharma Market

    21.1. Charles River Laboratories Acquired Distributed Bio

    21.2. Exscientia Acquired Austrian Company Allcyte

    21.3. Valo Health merged with Khosla Ventures Acquisition

    21.4. PathAI Merged with Labcorp

    22. AI In Pharma Market Future Outlook and Potential Analysis

    22.1. Global AI In Pharma Market In 2025 – Countries Offering Most New Opportunities

    22.2. Global AI In Pharma Market In 2025 – Segments Offering Most New Opportunities

    22.3. Global AI In Pharma Market In 2025 – Growth Strategies

    22.3.1. Market Trend Based Strategies

    22.3.2. Competitor Strategies

    23. Appendix

    23.1. Market Data Sources

    23.2. Research Methodology

    23.3. Currencies

    23.4. Research Inquiries

    23.5. The Business Research Company

    23.6. Copyright and Disclaimer

List Of Tables

    Table 1: Global AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 2: Global AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 3: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 4: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 5: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 6: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 7: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 8: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 9: Global AI In Pharma Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 10: Global AI In Pharma Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 11: Global AI In Pharma Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 12: Global AI In Pharma Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 13: Asia-Pacific Vaccine Market, COVID-19 Vaccines Approvals
  • Table 14: Asia-Pacific Vaccine Market, Number of COVID-19 Doses Administered, By Country
  • Table 15: Asia Pacific GDP Per Capita, 2015-2020, $
  • Table 16: Asia-Pacific Pharmaceuticals Industry Market Size, 2015-2025, $ Billion
  • Table 17: Asia Pacific Biologics Market Size, 2015-2025, $ Billion
  • Table 18: Asia Pacific Software Products Market Size, 2015-2025, $ Billion
  • Table 19: Asia-Pacific AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 20: Asia-Pacific AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 21: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 22: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 23: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 24: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 25: China Vaccine Market, COVID-19 Vaccines Approvals
  • Table 26: China GDP Per Capita, 2015-2020, $
  • Table 27: China, Pharmaceuticals Industry Market Size, 2015-2025, $ Billion
  • Table 28: China Biologics Market Size, 2015-2025, $ Billion
  • Table 29: China Software Products Market Size, 2015-2025, $ Billion
  • Table 30: China AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 31: China AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 32: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 33: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 34: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 35: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 36: India AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 37: India AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 38: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 39: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 40: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 41: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 42: Japan AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 43: Japan AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 44: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 45: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 46: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 47: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 48: Australia AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 49: Australia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 50: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 51: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 52: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 53: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 54: Indonesia AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 55: Indonesia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 56: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 57: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 58: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 59: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 60: South Korea AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 61: South Korea AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 62: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 63: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 64: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 65: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 66: Western Europe AI In Pharma Market, COVID-19 Vaccines Approvals
  • Table 67: Western Europe AI In Pharma Market, Number of COVID-19 Doses Administered, By Country
  • Table 68: Western Europe GDP Per Capita, 2015-2020, $
  • Table 69: Western Europe, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
  • Table 70: Western Europe Biologics Market Size, 2015-2025, $ Billion
  • Table 71: Western Europe Software Products Market Size, 2015-2025, $ Billion
  • Table 72: Western Europe AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 73: Western Europe AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 74: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 75: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 76: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 77: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 78: UK AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 79: UK AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 80: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 81: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 82: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 83: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 84: Germany AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 85: Germany AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 86: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 87: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 88: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 89: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 90: France AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 91: France AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 92: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 93: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 94: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 95: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 96: Western Europe AI In Pharma Market, COVID-19 Vaccines Approvals
  • Table 97: Eastern Europe AI In Pharma Market, Number of COVID-19 Doses Administered, By Country
  • Table 98: Eastern Europe GDP Per Capita, 2015-2020, $
  • Table 99: Eastern Europe, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
  • Table 100:Eastern Europe Biologics Market Size, 2015-2025, $ Billion
  • Table 101:Eastern Europe Software Products Market Size, 2015-2025, $ Billion
  • Table 102: Eastern Europe AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 103: Eastern Europe AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 104: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 105: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 106: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 107: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 108: Russia AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 109: Russia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 110: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 111: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 112: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 113: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 114: North America Vaccine Market, COVID-19 Vaccines Approvals
  • Table 115: North America Vaccine Market, Number of COVID-19 Doses Administered, By Country
  • Table 116: North America GDP Per Capita, 2015-2020, $
  • Table 117: North America, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
  • Table 118: North America Biologics Market Size, 2015-2025, $ Billion
  • Table 119: North America Software Products Market Size, 2015-2025, $ Billion
  • Table 120: North America AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 121: North America AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 122: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 123: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 124: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 125: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 126: USA Vaccine Market, COVID-19 Vaccines Approvals
  • Table 127: USA GDP Per Capita, 2015-2020, $
  • Table 128: USA Home, Pharmaceuticals Industry Market Size, 2015-2025, $ Billion
  • Table 129: USA Biologics Market Size, 2015-2025, $ Billion
  • Table 130: USA Biologics Market Size, 2015-2025, $ Billion
  • Table 131: USA AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 132: USA AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 133: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 134: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 135: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 136: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 137: South America Vaccine Market, COVID-19 Vaccines Approvals
  • Table 138: South America Vaccine Market, Number of COVID-19 Doses Administered, By Country
  • Table 139: South America GDP Per Capita, 2015-2020, $
  • Table 140: South America, Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
  • Table 141: South America Biologics Market Size, 2015-2025, $ Billion
  • Table 142: South America Software Products Market Size, 2015-2025, $ Billion
  • Table 143: South America AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 144: South America AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 145: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 146: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 147: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 148: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 149: Brazil AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 150: Brazil AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 151: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 152: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 153: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 154: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 155: Middle East Vaccine Market, COVID-19 Vaccines Approvals
  • Table 156: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country
  • Table 157: Middle East GDP Per Capita, 2015-2020, $
  • Table 158: Middle East Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
  • Table 159: Middle East Biologics Market Size, 2015-2025, $ Billion
  • Table 160: Western Europe Biologics Market Size, 2015-2025, $ Billion
  • Table 161: Middle East AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 162: Middle East AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 163: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 164: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 165: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 166: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 167: Africa AI In Pharma Market, COVID-19 Vaccines Approvals
  • Table 168: Africa AI In Pharma Market, Number of COVID-19 Doses Administered, By Country
  • Table 169: Africa GDP Per Capita, 2015-2020, $
  • Table 170: Africa Pharmaceuticals Industry Market Size, By Country, 2015-2025, $ Billion
  • Table 171: Africa Biologics Market Size, 2015-2025, $ Billion
  • Table 172: Africa Biologics Market Size, 2015-2025, $ Billion
  • Table 173: Africa AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Table 174: Africa AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 175: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 176: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 177: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 178: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 179: Global AI In Pharma Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Table 180: IBM Watson Health – Financial Overview, 2016 - 2020, $ Billion
  • Table 181: Alphabet Inc. – Financial Overview, 2016 - 2020, $ Billion
  • Table 182: Nvidia Corporation – Financial Overview, 2016 - 2020, $ Billion
  • Table 183: Global AI In Pharma Market Size Gain ($ Million), 2020 – 2025, By Country
  • Table 184: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Technology, 2020 – 2025
  • Table 185: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Drug Type, 2020 – 2025
  • Table 186: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025
  • Table 187: Artificial Intelligence (AI) In Pharma - Market Data Sources

List Of Figures

    Figure 1: Global Artificial Intelligence (AI) In Pharma Market Segmentation By Geography
  • Figure 2: Global Artificial Intelligence (AI) In Pharma Market Segmentation By Technology
  • Figure 3: Global Artificial Intelligence (AI) In Pharma Market Segmentation By Drug Type
  • Figure 4: Global AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 5: Global AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 6: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 7: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 8: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 9: Global AI In Pharma Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 10: Global AI In Pharma Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 11: Asia-Pacific AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 12: Asia-Pacific AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 13: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 14: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 15: China AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 16: China AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 17: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 18: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 19: India AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 20: India AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 21: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 22: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 23: Japan AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 24: Japan AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 25: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 26: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 27: Australia AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 28: Australia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 29: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 30: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 31: Indonesia AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 32: Indonesia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 33: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 34: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 35: South Korea AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 36: South Korea AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 37: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 38: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 39: Western Europe AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 40: Western Europe AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 41: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 42: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 43: UK AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 44: UK AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 45: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 46: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 47: Germany AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 48: Germany AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 49: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 50: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 51: France AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 52: France AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 53: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 54: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 55: Eastern Europe AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 56: Eastern Europe AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 57: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 58: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 59: Russia AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 60: Russia AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 61: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 62: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 63: North America AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 64: North America AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 65: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 66: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 67: USA AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 68: USA AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 69: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 70: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 71: South America AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 72: South America AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 73: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 74: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 75: Brazil AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 76: Brazil AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 77: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 78: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 79: Middle East AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 80: Middle East AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 81: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 82: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 83: Africa AI In Pharma Market, Historic, 2015 – 2020, $ Million
  • Figure 84: Africa AI In Pharma Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 85: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 86: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 87: Global AI In Pharma Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
  • Figure 88: IBM Watson Health – Financial Overview, 2016 – 2020, $ Billion
  • Figure 89: Alphabet Inc. – Financial Overview, 2016 – 2020, $ Billion
  • Figure 90: Nvidia Corporation – Financial Overview, 2016 – 2020, $ Billion
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report